These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 18716047)
1. Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test. van Rijn AF; van Rossum LG; Deutekom M; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB J Public Health (Oxf); 2008 Dec; 30(4):461-5. PubMed ID: 18716047 [TBL] [Abstract][Full Text] [Related]
2. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy? van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149 [TBL] [Abstract][Full Text] [Related]
3. Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network. Young WF; McGloin J; Zittleman L; West DR; Westfall JM J Rural Health; 2007; 23(3):238-45. PubMed ID: 17565524 [TBL] [Abstract][Full Text] [Related]
4. Validation of self-reported history of colorectal cancer screening. Khoja S; McGregor SE; Hilsden RJ Can Fam Physician; 2007 Jul; 53(7):1192-7. PubMed ID: 17872816 [TBL] [Abstract][Full Text] [Related]
5. Getting adequate information across to colorectal cancer screening subjects can be difficult. van Rijn AF; van Rossum LG; Deutekom M; Laheij RJ; Bossuyt PM; Fockens P; Dekker E; Jansen JB J Med Screen; 2008; 15(3):149-52. PubMed ID: 18927098 [TBL] [Abstract][Full Text] [Related]
6. The view from two sides: a qualitative study of community and medical perspectives on screening for colorectal cancer using FOBT. Clavarino AM; Janda M; Hughes KL; Del Mar C; Tong S; Stanton WR; Aitken JF; Leggett BA; Newman B Prev Med; 2004 Sep; 39(3):482-90. PubMed ID: 15313087 [TBL] [Abstract][Full Text] [Related]
7. Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing? Tong S; Hughes K; Oldenburg B; Del Mar C Intern Med J; 2004; 34(9-10):532-8. PubMed ID: 15482265 [TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer screening among men and women in the United States. Peterson NB; Murff HJ; Ness RM; Dittus RS J Womens Health (Larchmt); 2007; 16(1):57-65. PubMed ID: 17324097 [TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer mass screening event utilising quantitative faecal occult blood test. Chew MH; Suzanah N; Ho KS; Lim JF; Ooi BS; Tang CL; Eu KW Singapore Med J; 2009 Apr; 50(4):348-53. PubMed ID: 19421676 [TBL] [Abstract][Full Text] [Related]
10. Informed decision-making and colorectal cancer screening: is it occurring in primary care? Ling BS; Trauth JM; Fine MJ; Mor MK; Resnick A; Braddock CH; Bereknyei S; Weissfeld JL; Schoen RE; Ricci EM; Whittle J Med Care; 2008 Sep; 46(9 Suppl 1):S23-9. PubMed ID: 18725829 [TBL] [Abstract][Full Text] [Related]
11. Psychosocial factors associated with the adherence to a colorectal cancer screening program. Gili M; Roca M; Ferrer V; Obrador A; Cabeza E Cancer Detect Prev; 2006; 30(4):354-60. PubMed ID: 16963195 [TBL] [Abstract][Full Text] [Related]
12. Validation of self-reported colorectal cancer (CRC) screening in a study of ethnically diverse first-degree relatives of CRC cases. Bastani R; Glenn BA; Maxwell AE; Ganz PA; Mojica CM; Chang LC Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):791-8. PubMed ID: 18381469 [TBL] [Abstract][Full Text] [Related]
13. Attitudes and knowledge of colorectal cancer and screening in Hong Kong: a population-based study. Wong BC; Chan AO; Wong WM; Hui WM; Kung HF; Lam SK J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):41-6. PubMed ID: 16706810 [TBL] [Abstract][Full Text] [Related]
14. A multimedia patient education program on colorectal cancer screening increases knowledge and willingness to consider screening among Hispanic/Latino patients. Makoul G; Cameron KA; Baker DW; Francis L; Scholtens D; Wolf MS Patient Educ Couns; 2009 Aug; 76(2):220-6. PubMed ID: 19250791 [TBL] [Abstract][Full Text] [Related]
15. Trends in colorectal cancer test use in the medicare population, 1998-2005. Schenck AP; Peacock SC; Klabunde CN; Lapin P; Coan JF; Brown ML Am J Prev Med; 2009 Jul; 37(1):1-7. PubMed ID: 19423273 [TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan. Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635 [TBL] [Abstract][Full Text] [Related]
17. The reasons of general practitioners for promoting colorectal cancer mass screening in France. Berchi C; Dupuis JM; Launoy G Eur J Health Econ; 2006 Jun; 7(2):91-8. PubMed ID: 16474967 [TBL] [Abstract][Full Text] [Related]
18. Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain). Peris M; Espinàs JA; Muñoz L; Navarro M; Binefa G; Borràs JM; J Med Screen; 2007; 14(2):81-6. PubMed ID: 17626707 [TBL] [Abstract][Full Text] [Related]
19. Better acceptance of Fecal Occult Blood Test (FOBT) for colorectal cancer screening during hospitalization. Keller R; Schätzle A; Flieger D; Christl SU; Fischbach W Z Gastroenterol; 2003 Jul; 41(7):655-8. PubMed ID: 12858236 [TBL] [Abstract][Full Text] [Related]
20. Trends in colorectal cancer screening disparities in people aged 50-64 years, 2000-2005. Trivers KF; Shaw KM; Sabatino SA; Shapiro JA; Coates RJ Am J Prev Med; 2008 Sep; 35(3):185-93. PubMed ID: 18617355 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]